Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > TD did the buying

<< Previous

Bullboard Posts

Next >>

Comment by sweenbyon Mar 31, 2010 10:35pm

228 Views

Post# 16947131

RE: RE: TD did the buying

Penson is a brokerage among other financial products. Big co. Could be anybody using them. Maybe somebody having to settle. Have to wait for the major buying to come in and it will as we get closer to the drill results. Looking forward to it. glta

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario